Published in Strahlenther Onkol on April 01, 2001
Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment. Curr Cancer Ther Rev (2011) 1.40
DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol (2010) 1.21
Prolonged regression of metastatic leptomeningeal breast cancer that has failed conventional therapy: a case report and review of the literature. J Breast Cancer (2013) 0.99
Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases. J Neurooncol (2017) 0.75
Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol (2013) 2.06
One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery. Strahlenther Onkol (2012) 0.95
Fractionated and single-dose radiotherapy for heterotopic bone formation in patients with spinal cord injury. A phase-I/II study. Strahlenther Onkol (2001) 0.94
Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer (2001) 0.88
Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol (2013) 0.85
Extrarenal abnormalities in Tc-99m DTPA renal perfusion studies due to hypervascularized tumors. Clin Nucl Med (1988) 0.84
Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur J Nucl Med (1993) 0.78
Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment. Strahlenther Onkol (1998) 0.78
The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma. Nucl Med Commun (1993) 0.77
[Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing]. Pathologe (2004) 0.77
The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid. Semin Oncol (1994) 0.75
Reply to the letter of Junginger et al. Strahlenther Onkol 2013 DOI 10.1007/s00066-013-0353-y. Strahlenther Onkol (2013) 0.75
[The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients]. Strahlenther Onkol (1994) 0.75
IORT of carcinoma of the extrahepatic bile ducts. Front Radiat Ther Oncol (1997) 0.75
[Local recurrence in premenopausal women with breast cancer: risk factors and effect of therapy]. Strahlenther Onkol (2001) 0.75
[Improved survival rate by postoperative radiotherapy in postmenopausal high risk patients with breast carcinoma]. Strahlenther Onkol (1999) 0.75
Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)? Prog Clin Biol Res (1994) 0.75
[Lobular carcinoma in situ as a component of breast cancer points to no contraindication for breast-conserving therapy]. Strahlenther Onkol (2001) 0.75
Treatment planning of tangential breast irradiation using a simulator with CT-option compared to a conventional CT. Strahlenther Onkol (1999) 0.75
[Does neoadjuvant therapy promote or delay metastasis in breast cancer?]. Strahlenther Onkol (2000) 0.75
[Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast]. Strahlenther Onkol (1999) 0.75
[Sentinel node biopsy in breast cancer]. Nuklearmedizin (2004) 0.75
[Improved survival rates with prophylactic whole-brain irradiation in small-cell bronchial carcinoma]. Strahlenther Onkol (1999) 0.75
Clinical relevance of positron emission tomography (PET) in treatment control and relapse of Hodgkin's disease. Strahlenther Onkol (2001) 0.75
[Radiation therapy of chronic pancreatitis. Case report]. Strahlenther Onkol (1998) 0.75
[Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids]. Nuklearmedizin (1987) 0.75
[Meta-analysis confirms improved survival rate by locoregional radiotherapy of breast carcinoma]. Strahlenther Onkol (2000) 0.75